According to a report by Santé publique France, the incidence and mortality rates of motor neuron diseases, including Charcot's disease, have remained stable over the past ten years. However, it identifies three specific regions—Brittany, Occitanie, and Auvergne—as being particularly affected by these rare yet formidable disorders. These diseases lead to progressive paralysis and can result in death within 2 to 5 years after diagnosis, underscoring the urgency of addressing them.

Charcot's disease, or Amyotrophic Lateral Sclerosis (ALS), accounts for approximately 90% of motor neuron disease cases in adults and is characterized by a complex understanding and lack of a curative treatment. The data updated by Santé publique France aims to shed light on the epidemiology of these diseases and help refine health care services and research initiatives. This effort is critical for monitoring public health, especially in regions where these diseases manifest more frequently.

As motor neuron diseases continue to pose significant challenges to public health in France, the report highlights the need for continued research and resource allocation, particularly in the affected areas. The information gathered will support clinicians and researchers in better understanding the disease dynamics and potentially improving outcomes through enhanced health care approaches.